Category Archives: Gene Therapy

Muscular Myopathy in Dog X-Linked Myotubular Myopathy in Dogs and related Gene Therapy. By: Amanda Tawde … Continue reading →

InfiniSauce - Episode 6 - Gene Therapy InfiniSauce - Episode 6 - Gene Therapy Towsty adventures through the Modsauce modpack - watch out world! Get the ATLauncher and the Modsauce Pack Here: http://www.atlauncher.com/ Get Minecraft... By: Infinity Labs … Continue reading →

Homeopathic gene therapy +'d to my water supply The people who manage and run Welsh Water have allowed an unknown person to add homeopathic gene therapy targeted at my telomeres on my DNA strands increasin... By: Saul Allaway … Continue reading →

P02-Gene Therapy By: seung-jae Kim … Continue reading →

Dr. Campbell: New gene therapy may replace pacemaker implants July 30, 2014 WNCN. By: DrKevinCampbellMD … Continue reading →

Joint research projects by NUIG and the Mayo Clinic will focus on a number of key strategic areas, including adult stem-cell therapy, gene therapy, biomaterials and biomedical engineering, the two institutes have said. Illustration: Getty NUI Galway and the Mayo Clinic in the US plan to collaborate on clinical trials using regenerative medicine, following the signing of a memorandum of understanding between the two institutes. The joint research projects will focus on a number of key strategic areas, including adult stem-cell therapy, gene therapy, biomaterials and biomedical engineering, the two institutes have said. The Mayo Clinic and NUIGs Regenerative Medicine Institute have worked closely with each other for a number of years. Both have licensed cell manufacturing facilities, and student and staff exchange programmes between Galway and the US will continue. Welcoming the agreement, NUIG president Dr Jim Browne has noted that his university has Irelands only facility licensed to produce stem cells for human use. A new clinical and translational research facility for conducting clinical trials with patients will be complete in early 2015, he said. See the rest here: NUI Galway in joint stem cell project with Mayo Clinic … Continue reading →

3 Minute Thesis 2014 Winner - Gene therapy spray: A breath of fresh air - Presentation Presenter: Harshavardini Padmanabhan Faculty of Health Sciences School of Paediatrics Thesis area: Aerosol Airway Gene Transfer Technique for Clinical Use Su... By: University of Adelaide … Continue reading →

Sainik School Bijapur, Mahaling, Gene Therapy to Adjust Heartbeat,9 Sept 2014 Sainik School Bijapur, Mahaling, Gene Therapy to Adjust Heartbeat,9 Sept 2014. By: D.Vijaya Kumar Kumar … Continue reading →

27 - Gene Therapy by Jasmine Costa 27 - Gene Therapy by Jasmine Costa. By: Bruce Rasmussen … Continue reading →

Xenon Pharmaceuticals, an early-stage biotech with a gene therapy discovery platform for rare diseases, filed on Wednesday with the SEC to raise up to $52 million in an initial public offering. Xenon has a number of collaboration and licensing agreements with large pharmaceuticals including Teva, Genentech and Merck for its preclinical research. The company's discovery platform was used to develop uniQure's Glybera treatment for orphan disease lipoprotein lipase deficiency, the first gene therapy approved in the EU. February IPO uniQure ( QURE ) priced above its range but ended the first day down 14% and now trades down 36% below the IPO price. Xenon is eligible to receive mid single-digit royalties on net sales of Glybera. Teva is in Phase 2 trials for a gene therapy discovered by Xenon that is being developed to treat osteoarthritis. Genentech was cleared to begin a Phase 1 trial for Xenon's pain treatment and Merck is in preclinical development for cardiovascular disease. Xenon also has a variety of preclinical therapies for both orphan diseases (such as Dravet Syndrome) and large-market conditions (including acne). Primary shareholders include Medpace (16%), Lipterx (11%), InterWest Partners (9%), Fidelity (7%), Invesco (5%) and CEO Simon Pimstone (4%). The Burnaby, … Continue reading →